“Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks” (2025) Canadian Oncology Today, 2(3), pp. 22–28. doi:10.58931/cot.2025.2342.